☆ 4.7 Article

Screening of natural product libraries in MCF7 cell line reveals the pro-apoptotic properties of b tetralone

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

A recent update on small-molecule kinase inhibitors for targeted cancer therapy and their therapeutic insights from mass spectrometry-based proteomic analysis

Pey Yee Lee et al.

Summary: Kinases play important roles in regulating biological processes and are associated with cancer. Small-molecule kinase inhibitors have revolutionized cancer treatment, but their selectivity and effectiveness are still challenging. This review provides an overview of the role of kinases in carcinogenesis, the progress of approved small-molecule kinase inhibitors, and the application of mass spectrometry-based proteomics strategies in kinase inhibitor design. It also discusses the challenges and outlook of mass spectrometry-based proteomics techniques for kinase drug research.

FEBS JOURNAL (2023)

Add to Collection

Review Environmental Sciences

Anticancer properties of medicinal plants and their bioactive compounds against breast cancer: a review on recent investigations

Muhammad Idrees Khan et al.

Summary: This article introduces the role of medicinal plants and their bioactive compounds in the treatment of breast cancer. It is found that compounds in natural products have anti-cancer effects on breast cancer cells, and they work through various mechanisms, including inhibiting apoptotic pathways, blocking the cell cycle, and activating autophagy. In addition, they also exhibit anti-angiogenesis and anti-metastatic effects. However, the chemopreventive effects of different compounds on breast cancer vary.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)

Add to Collection

Article Chemistry, Medicinal

Research progress in pharmacological activities and structure-activity relationships of tetralone scaffolds as pharmacophore and fluorescent skeleton

Kangjia Sheng et al.

Summary: Tetralone and its derivatives, as important structural scaffolds for potential novel drugs, exhibit diverse biological activities and have attracted attention from medicinal chemists. Research focuses on pharmacological activities, structure-activity relationships, and docking studies, aiming to provide insights for further exploration of tetralone derivatives.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Oncology

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019

Jonathan M. Kocarnik et al.

Summary: The global burden of cancer is substantial and growing, with differences in burden based on Sociodemographic Index (SDI). The largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles from 2010 to 2019.

JAMA ONCOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

New and Emerging Targeted Therapies for Advanced Breast Cancer

Kristie H. Lau et al.

Summary: This article discusses the incidence and classification of breast cancer in the United States, and explores the main treatment methods, including surgery, radiation therapy, chemotherapy, endocrine therapy, and targeted therapy. It also highlights the research focus on triple-negative breast cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Oncology

Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer

Angelica Ferrando-Diez et al.

Summary: In recent years, the development of anti-HER2 treatments has improved the landscape of HER2-positive breast cancer. However, relapse remains a major issue. This review focuses on the milestones that have impacted the disease and highlights the importance of understanding the underlying molecular biology for optimizing treatment options. The review also discusses the role of triple-positive disease and modulation of the immune response in treatment and prognosis.

CANCERS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Current Molecular Combination Therapies Used for the Treatment of Breast Cancer

Yiling Wang et al.

Summary: Breast cancer is the second leading cause of death for women worldwide. Combination therapies have emerged as promising treatment options, offering increased effectiveness and lower toxicity compared to monotherapies. The use of multidisciplinary technologies has the potential to further optimize combination therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

Current and future burden of breast cancer: Global statistics for 2020 and 2040

Melina Arnold et al.

Summary: Breast cancer is the most commonly diagnosed cancer worldwide, with over 2.3 million new cases and 685,000 deaths in 2020. There is significant geographic variation in incidence rates, with lower rates in some Asian and African countries and higher rates in countries like Australia, New Zealand, Northern America, and parts of Europe. Mortality rates show less variation, but transitioning countries still bear a disproportionate burden of breast cancer deaths. By 2040, the burden of breast cancer is predicted to increase further due to population growth and ageing. Global efforts are needed to address this growing burden, especially in transitioning countries where incidence rates are rising rapidly and mortality rates remain high.

BREAST (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3Kα against non-small cell lung cancer: a computational study

Debojyoti Halder et al.

Summary: This study used computational drug discovery tools to investigate non-small cell lung cancer (NSCLC) and aimed to identify potential protein kinase inhibitors through molecular docking and dynamics approach. The research discovered that molecules 6943 and 34100 showed better results compared to the PI3K inhibitor Copanlisib in docking assessment, ADMET analysis, and molecular dynamics simulation.

RSC ADVANCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

The Discovery of New Drug-Target Interactions for Breast Cancer Treatment

Jiali Song et al.

Summary: The study developed a feature-based method, PsePDC-DTIs, to predict drug-target interactions (DTIs) for breast cancer research, achieving good prediction results and exploring new treatment targets for breast cancer.

MOLECULES (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Natural products in drug discovery: advances and opportunities

Atanas G. Atanasov et al.

Summary: Natural products and their analogues have historically played a significant role in pharmacotherapy, however, they also present challenges. Recent technological and scientific developments are addressing these challenges and revitalizing interest in natural products as drug leads, particularly for combating antimicrobial resistance.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function

Kirsteen J. Campbell et al.

Summary: MCL-1 plays a crucial role in breast cancer, with its anti-apoptotic function being key. Deletion or inhibition of MCL-1 relies on pro-apoptotic proteins BAX/BAK for its anti-tumor effects, and it also influences stem cell activity in breast cancer cells.

CELL DEATH AND DIFFERENTIATION (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Kinase drug discovery 20 years after imatinib: progress and future directions

Philip Cohen et al.

Summary: Advances in improving the potency and specificity of small-molecule protein kinase inhibitors over the past 20 years have had a significant impact on the treatment of cancers and non-cancerous conditions. Efforts are being made to address the challenge of drug resistance to kinase inhibitors, and future directions in kinase drug discovery are being discussed.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection

Review Oncology

Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer

Xue Yang et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)

Add to Collection

Review Oncology

The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors

Helei Hou et al.

CANCER CELL INTERNATIONAL (2019)

Add to Collection

Review Oncology

Targeted Therapies for Triple-Negative Breast Cancer

Tomas G. Lyons

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Apoptosis: A Target for Anticancer Therapy

Claire M. Pfeffer et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application

Ana M. L. Seca et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Kinase-targeted cancer therapies: progress, challenges and future directions

Khushwant S. Bhullar et al.

MOLECULAR CANCER (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival

Xuan Pu et al.

APOPTOSIS (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Protein Kinase Targets in Breast Cancer

Marilina Garcia-Aranda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo

Emma M. Carrington et al.

CELL DEATH AND DIFFERENTIATION (2017)

Add to Collection

Review Oncology

Targeted therapies in breast cancer: New challenges to fight against resistance

Viviana Masoud et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Biochemical Research Methods

Computational protein-ligand docking and virtual drug screening with the AutoDock suite

Stefano Forli et al.

NATURE PROTOCOLS (2016)

Add to Collection

Review Pharmacology & Pharmacy

P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia

Stefania Trino et al.

FRONTIERS IN PHARMACOLOGY (2016)

Add to Collection

Review Oncology

Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp

Khalid O. Alfarouk et al.

CANCER CELL INTERNATIONAL (2015)

Add to Collection

Review Cell Biology

Evading apoptosis in cancer

Kaleigh Fernald et al.

TRENDS IN CELL BIOLOGY (2013)

Add to Collection

Review Obstetrics & Gynecology

MECHANISMS OF CHEMOTHERAPEUTIC DRUG RESISTANCE IN CANCER THERAPY-A QUICK REVIEW

Fu-Shing Liu

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.